Tumor development and progression are strongly linked to inflammation and the presence of tumor-associated macrophages (TAMs). In murine tumors, antitumor activity can be achieved by targeting TAM recruitment, survival, activation, polarization, effector signaling, or extracellular matrix interactions. Thus, it may be possible to increase the efficacy of conventional cancer therapeutic strategies by targeting TAMs. (copyright)2005 American Association for Cancer Research.

Targeting myelomonocytic cells to revert inflammation-dependent cancer promotion / A. Mantovani, M.P. Colombo. - In: CANCER RESEARCH. - ISSN 0008-5472. - 65:20(2005 Oct 15), pp. 9113-9116. [10.1158/0008-5472.CAN-05-2714]

Targeting myelomonocytic cells to revert inflammation-dependent cancer promotion

A. Mantovani
Primo
;
2005

Abstract

Tumor development and progression are strongly linked to inflammation and the presence of tumor-associated macrophages (TAMs). In murine tumors, antitumor activity can be achieved by targeting TAM recruitment, survival, activation, polarization, effector signaling, or extracellular matrix interactions. Thus, it may be possible to increase the efficacy of conventional cancer therapeutic strategies by targeting TAMs. (copyright)2005 American Association for Cancer Research.
antineoplastic activity; cancer inhibition; cancer survival; carcinogenesis; cell interaction; cell survival; chronic inflammation; effector cell; extracellular matrix; inflammation; leukemia cell; myelomonocytic leukemia; nonhuman; polarization; priority journal; review; target cell; tumor associated leukocyte; tumor growth; tumor promotion; cyclooxygenase 2
Settore MED/04 - Patologia Generale
15-ott-2005
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/8955
Citazioni
  • ???jsp.display-item.citation.pmc??? 33
  • Scopus 91
  • ???jsp.display-item.citation.isi??? 74
social impact